Title |
Insulin Stimulates Adipogenesis through the Akt-TSC2-mTORC1 Pathway
|
---|---|
Published in |
PLOS ONE, July 2009
|
DOI | 10.1371/journal.pone.0006189 |
Pubmed ID | |
Authors |
Hui H. Zhang, Jingxiang Huang, Katrin Düvel, Bernard Boback, Shulin Wu, Rachel M. Squillace, Chin-Lee Wu, Brendan D. Manning |
Abstract |
The signaling pathways imposing hormonal control over adipocyte differentiation are poorly understood. While insulin and Akt signaling have been found previously to be essential for adipogenesis, the relative importance of their many downstream branches have not been defined. One direct substrate that is inhibited by Akt-mediated phosphorylation is the tuberous sclerosis complex 2 (TSC2) protein, which associates with TSC1 and acts as a critical negative regulator of the mammalian target of rapamycin (mTOR) complex 1 (mTORC1). Loss of function of the TSC1-TSC2 complex results in constitutive mTORC1 signaling and, through mTORC1-dependent feedback mechanisms and loss of mTORC2 activity, leads to a concomitant block of Akt signaling to its other downstream targets. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Australia | 1 | 33% |
United States | 1 | 33% |
Unknown | 1 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 67% |
Practitioners (doctors, other healthcare professionals) | 1 | 33% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 3 | 1% |
Germany | 2 | <1% |
United Kingdom | 2 | <1% |
Netherlands | 1 | <1% |
Chile | 1 | <1% |
Austria | 1 | <1% |
Japan | 1 | <1% |
Korea, Republic of | 1 | <1% |
Unknown | 279 | 96% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 72 | 25% |
Researcher | 52 | 18% |
Student > Master | 31 | 11% |
Student > Bachelor | 23 | 8% |
Student > Doctoral Student | 17 | 6% |
Other | 46 | 16% |
Unknown | 50 | 17% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 109 | 37% |
Biochemistry, Genetics and Molecular Biology | 72 | 25% |
Medicine and Dentistry | 27 | 9% |
Neuroscience | 6 | 2% |
Pharmacology, Toxicology and Pharmaceutical Science | 6 | 2% |
Other | 18 | 6% |
Unknown | 53 | 18% |